OSTEOPOROSIS INTERNATIONAL-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1004453, encodeId=aa4d100445391, content=偏重的研究方向：骨质疏松 经验分享：请问initial submit 7.22，status date 7.27，还是显示editor assigned，预计还要多久会有结果 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9d325448092, createdName=ms1000000995331571, createdTime=Sun Aug 01 19:27:22 CST 2021, time=2021-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181918, encodeId=830b118191810, content=偏重的研究方向：骨质疏松;筛查;成本效益分析 经验分享：大家好，我准备投一篇关于新的骨质疏松筛查工具的成本效益文章，因为一般这种文章文献数量很多所以我最后文献超了（要求45 我现在55）。请问各位这个如果投稿会被直接拒稿吗？还是可以在哪里说明一下？因为我看这个榨汁之前发表的一些成本效益分析文献数量也超过了45. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea56429884, createdName=ms6000000498436311, createdTime=Fri Jan 07 18:03:06 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181768, encodeId=1eac1181e6898, content=偏重的研究方向：骨质疏松 经验分享：20211227投的稿，30号状态更新editor assigned，至今状态不变，大家有经验吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37a06428636, createdName=ms8000001947639273, createdTime=Fri Jan 07 10:10:52 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095822, encodeId=f89c1095822bd, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566561, encodeId=506e56656109, content=20天审稿，给了3个月大修，一个月修回，一天接受，都没外送！神速！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27772543340, createdName=1252754dm51(暂无昵称), createdTime=Fri Feb 08 15:03:00 CST 2019, time=2019-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006118, encodeId=c5ab1006118e0, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：内固定物;有限元分析 经验分享：我8月2日投的，8月6日被拒绝！说他们编辑部讨论过我的文章，很遗憾不可以发表！没有任何修改意见……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d63b2925907, createdName=798200815, createdTime=Sun Aug 08 19:58:01 CST 2021, time=2021-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974458, encodeId=6d269e445829, content=偏重的研究方向：颌骨骨髓炎 经验分享：6.9投稿的，至今还在editor assigned，祈求好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/cx7lbf4aPYSqwzoXRP2UibyicD4eojmkpm4KjYpNROt1rmru0INbwt7bxcXh4v4fXLxCNvt08WZibBNkBWO7olZBQ/132, createdBy=6ad35224903, createdName=aqiongbb, createdTime=Thu Jun 17 19:53:30 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957199, encodeId=ea9995e19967, content=偏重的研究方向：生物力学;有限元分析 经验分享：我今天凌晨投稿的。不知道要等到什么时候了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d63b2925907, createdName=798200815, createdTime=Thu Apr 15 09:33:28 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553934, encodeId=9ddb553934b3, content=我是2月9投稿.目前还在审稿.焦急等待wxsession1f1cf044 2016-07-01 12:07:00 发表: 这个杂志我认为又快又好.我一个月接收, beContent=wxsession1f1cf044 2016-07-01 12:07:00 发表: 这个杂志我认为又快又好.我一个月接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/24/70bdcc438fd615b24ef997bb8d646928.jpg, createdBy=225f2012274, createdName=生如夏花之绚烂, createdTime=Tue Mar 20 00:00:00 CST 2018, time=2018-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548640, encodeId=2bcc548640b1, content=谢谢分享嚯嚯嚯 2017-08-11 16:57:00 发表: 好.值得一试, beContent=嚯嚯嚯 2017-08-11 16:57:00 发表: 好.值得一试, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/24/70bdcc438fd615b24ef997bb8d646928.jpg, createdBy=225f2012274, createdName=生如夏花之绚烂, createdTime=Fri Oct 27 00:00:00 CST 2017, time=2017-10-27, status=1, ipAttribution=)]

2021-08-01 ms1000000995331571

偏重的研究方向：骨质疏松
经验分享：请问initial submit 7.22，status date 7.27，还是显示editor assigned，预计还要多久会有结果

95 12

展开12条回复

[GetPortalCommentsPageByObjectIdResponse(id=1004453, encodeId=aa4d100445391, content=偏重的研究方向：骨质疏松 经验分享：请问initial submit 7.22，status date 7.27，还是显示editor assigned，预计还要多久会有结果 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9d325448092, createdName=ms1000000995331571, createdTime=Sun Aug 01 19:27:22 CST 2021, time=2021-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181918, encodeId=830b118191810, content=偏重的研究方向：骨质疏松;筛查;成本效益分析 经验分享：大家好，我准备投一篇关于新的骨质疏松筛查工具的成本效益文章，因为一般这种文章文献数量很多所以我最后文献超了（要求45 我现在55）。请问各位这个如果投稿会被直接拒稿吗？还是可以在哪里说明一下？因为我看这个榨汁之前发表的一些成本效益分析文献数量也超过了45. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea56429884, createdName=ms6000000498436311, createdTime=Fri Jan 07 18:03:06 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181768, encodeId=1eac1181e6898, content=偏重的研究方向：骨质疏松 经验分享：20211227投的稿，30号状态更新editor assigned，至今状态不变，大家有经验吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37a06428636, createdName=ms8000001947639273, createdTime=Fri Jan 07 10:10:52 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095822, encodeId=f89c1095822bd, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566561, encodeId=506e56656109, content=20天审稿，给了3个月大修，一个月修回，一天接受，都没外送！神速！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27772543340, createdName=1252754dm51(暂无昵称), createdTime=Fri Feb 08 15:03:00 CST 2019, time=2019-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006118, encodeId=c5ab1006118e0, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：内固定物;有限元分析 经验分享：我8月2日投的，8月6日被拒绝！说他们编辑部讨论过我的文章，很遗憾不可以发表！没有任何修改意见……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d63b2925907, createdName=798200815, createdTime=Sun Aug 08 19:58:01 CST 2021, time=2021-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974458, encodeId=6d269e445829, content=偏重的研究方向：颌骨骨髓炎 经验分享：6.9投稿的，至今还在editor assigned，祈求好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/cx7lbf4aPYSqwzoXRP2UibyicD4eojmkpm4KjYpNROt1rmru0INbwt7bxcXh4v4fXLxCNvt08WZibBNkBWO7olZBQ/132, createdBy=6ad35224903, createdName=aqiongbb, createdTime=Thu Jun 17 19:53:30 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957199, encodeId=ea9995e19967, content=偏重的研究方向：生物力学;有限元分析 经验分享：我今天凌晨投稿的。不知道要等到什么时候了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d63b2925907, createdName=798200815, createdTime=Thu Apr 15 09:33:28 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553934, encodeId=9ddb553934b3, content=我是2月9投稿.目前还在审稿.焦急等待wxsession1f1cf044 2016-07-01 12:07:00 发表: 这个杂志我认为又快又好.我一个月接收, beContent=wxsession1f1cf044 2016-07-01 12:07:00 发表: 这个杂志我认为又快又好.我一个月接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/24/70bdcc438fd615b24ef997bb8d646928.jpg, createdBy=225f2012274, createdName=生如夏花之绚烂, createdTime=Tue Mar 20 00:00:00 CST 2018, time=2018-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548640, encodeId=2bcc548640b1, content=谢谢分享嚯嚯嚯 2017-08-11 16:57:00 发表: 好.值得一试, beContent=嚯嚯嚯 2017-08-11 16:57:00 发表: 好.值得一试, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/24/70bdcc438fd615b24ef997bb8d646928.jpg, createdBy=225f2012274, createdName=生如夏花之绚烂, createdTime=Fri Oct 27 00:00:00 CST 2017, time=2017-10-27, status=1, ipAttribution=)]

2022-01-07 ms6000000498436311

偏重的研究方向：骨质疏松;筛查;成本效益分析
经验分享：大家好，我准备投一篇关于新的骨质疏松筛查工具的成本效益文章，因为一般这种文章文献数量很多所以我最后文献超了（要求45 我现在55）。请问各位这个如果投稿会被直接拒稿吗？还是可以在哪里说明一下？因为我看这个榨汁之前发表的一些成本效益分析文献数量也超过了45.

44 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1004453, encodeId=aa4d100445391, content=偏重的研究方向：骨质疏松 经验分享：请问initial submit 7.22，status date 7.27，还是显示editor assigned，预计还要多久会有结果 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9d325448092, createdName=ms1000000995331571, createdTime=Sun Aug 01 19:27:22 CST 2021, time=2021-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181918, encodeId=830b118191810, content=偏重的研究方向：骨质疏松;筛查;成本效益分析 经验分享：大家好，我准备投一篇关于新的骨质疏松筛查工具的成本效益文章，因为一般这种文章文献数量很多所以我最后文献超了（要求45 我现在55）。请问各位这个如果投稿会被直接拒稿吗？还是可以在哪里说明一下？因为我看这个榨汁之前发表的一些成本效益分析文献数量也超过了45. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea56429884, createdName=ms6000000498436311, createdTime=Fri Jan 07 18:03:06 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181768, encodeId=1eac1181e6898, content=偏重的研究方向：骨质疏松 经验分享：20211227投的稿，30号状态更新editor assigned，至今状态不变，大家有经验吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37a06428636, createdName=ms8000001947639273, createdTime=Fri Jan 07 10:10:52 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095822, encodeId=f89c1095822bd, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566561, encodeId=506e56656109, content=20天审稿，给了3个月大修，一个月修回，一天接受，都没外送！神速！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27772543340, createdName=1252754dm51(暂无昵称), createdTime=Fri Feb 08 15:03:00 CST 2019, time=2019-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006118, encodeId=c5ab1006118e0, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：内固定物;有限元分析 经验分享：我8月2日投的，8月6日被拒绝！说他们编辑部讨论过我的文章，很遗憾不可以发表！没有任何修改意见……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d63b2925907, createdName=798200815, createdTime=Sun Aug 08 19:58:01 CST 2021, time=2021-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974458, encodeId=6d269e445829, content=偏重的研究方向：颌骨骨髓炎 经验分享：6.9投稿的，至今还在editor assigned，祈求好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/cx7lbf4aPYSqwzoXRP2UibyicD4eojmkpm4KjYpNROt1rmru0INbwt7bxcXh4v4fXLxCNvt08WZibBNkBWO7olZBQ/132, createdBy=6ad35224903, createdName=aqiongbb, createdTime=Thu Jun 17 19:53:30 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957199, encodeId=ea9995e19967, content=偏重的研究方向：生物力学;有限元分析 经验分享：我今天凌晨投稿的。不知道要等到什么时候了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d63b2925907, createdName=798200815, createdTime=Thu Apr 15 09:33:28 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553934, encodeId=9ddb553934b3, content=我是2月9投稿.目前还在审稿.焦急等待wxsession1f1cf044 2016-07-01 12:07:00 发表: 这个杂志我认为又快又好.我一个月接收, beContent=wxsession1f1cf044 2016-07-01 12:07:00 发表: 这个杂志我认为又快又好.我一个月接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/24/70bdcc438fd615b24ef997bb8d646928.jpg, createdBy=225f2012274, createdName=生如夏花之绚烂, createdTime=Tue Mar 20 00:00:00 CST 2018, time=2018-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548640, encodeId=2bcc548640b1, content=谢谢分享嚯嚯嚯 2017-08-11 16:57:00 发表: 好.值得一试, beContent=嚯嚯嚯 2017-08-11 16:57:00 发表: 好.值得一试, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/24/70bdcc438fd615b24ef997bb8d646928.jpg, createdBy=225f2012274, createdName=生如夏花之绚烂, createdTime=Fri Oct 27 00:00:00 CST 2017, time=2017-10-27, status=1, ipAttribution=)]

2022-01-07 ms8000001947639273

偏重的研究方向：骨质疏松
经验分享：20211227投的稿，30号状态更新editor assigned，至今状态不变，大家有经验吗？

40 0

[GetPortalCommentsPageByObjectIdResponse(id=1004453, encodeId=aa4d100445391, content=偏重的研究方向：骨质疏松 经验分享：请问initial submit 7.22，status date 7.27，还是显示editor assigned，预计还要多久会有结果 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9d325448092, createdName=ms1000000995331571, createdTime=Sun Aug 01 19:27:22 CST 2021, time=2021-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181918, encodeId=830b118191810, content=偏重的研究方向：骨质疏松;筛查;成本效益分析 经验分享：大家好，我准备投一篇关于新的骨质疏松筛查工具的成本效益文章，因为一般这种文章文献数量很多所以我最后文献超了（要求45 我现在55）。请问各位这个如果投稿会被直接拒稿吗？还是可以在哪里说明一下？因为我看这个榨汁之前发表的一些成本效益分析文献数量也超过了45. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea56429884, createdName=ms6000000498436311, createdTime=Fri Jan 07 18:03:06 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181768, encodeId=1eac1181e6898, content=偏重的研究方向：骨质疏松 经验分享：20211227投的稿，30号状态更新editor assigned，至今状态不变，大家有经验吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37a06428636, createdName=ms8000001947639273, createdTime=Fri Jan 07 10:10:52 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095822, encodeId=f89c1095822bd, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566561, encodeId=506e56656109, content=20天审稿，给了3个月大修，一个月修回，一天接受，都没外送！神速！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27772543340, createdName=1252754dm51(暂无昵称), createdTime=Fri Feb 08 15:03:00 CST 2019, time=2019-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006118, encodeId=c5ab1006118e0, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：内固定物;有限元分析 经验分享：我8月2日投的，8月6日被拒绝！说他们编辑部讨论过我的文章，很遗憾不可以发表！没有任何修改意见……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d63b2925907, createdName=798200815, createdTime=Sun Aug 08 19:58:01 CST 2021, time=2021-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974458, encodeId=6d269e445829, content=偏重的研究方向：颌骨骨髓炎 经验分享：6.9投稿的，至今还在editor assigned，祈求好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/cx7lbf4aPYSqwzoXRP2UibyicD4eojmkpm4KjYpNROt1rmru0INbwt7bxcXh4v4fXLxCNvt08WZibBNkBWO7olZBQ/132, createdBy=6ad35224903, createdName=aqiongbb, createdTime=Thu Jun 17 19:53:30 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957199, encodeId=ea9995e19967, content=偏重的研究方向：生物力学;有限元分析 经验分享：我今天凌晨投稿的。不知道要等到什么时候了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d63b2925907, createdName=798200815, createdTime=Thu Apr 15 09:33:28 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553934, encodeId=9ddb553934b3, content=我是2月9投稿.目前还在审稿.焦急等待wxsession1f1cf044 2016-07-01 12:07:00 发表: 这个杂志我认为又快又好.我一个月接收, beContent=wxsession1f1cf044 2016-07-01 12:07:00 发表: 这个杂志我认为又快又好.我一个月接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/24/70bdcc438fd615b24ef997bb8d646928.jpg, createdBy=225f2012274, createdName=生如夏花之绚烂, createdTime=Tue Mar 20 00:00:00 CST 2018, time=2018-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548640, encodeId=2bcc548640b1, content=谢谢分享嚯嚯嚯 2017-08-11 16:57:00 发表: 好.值得一试, beContent=嚯嚯嚯 2017-08-11 16:57:00 发表: 好.值得一试, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/24/70bdcc438fd615b24ef997bb8d646928.jpg, createdBy=225f2012274, createdName=生如夏花之绚烂, createdTime=Fri Oct 27 00:00:00 CST 2017, time=2017-10-27, status=1, ipAttribution=)]

2021-12-28 小动量

同一杂志社不同期刊如何转投（transfer）？

43 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1004453, encodeId=aa4d100445391, content=偏重的研究方向：骨质疏松 经验分享：请问initial submit 7.22，status date 7.27，还是显示editor assigned，预计还要多久会有结果 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9d325448092, createdName=ms1000000995331571, createdTime=Sun Aug 01 19:27:22 CST 2021, time=2021-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181918, encodeId=830b118191810, content=偏重的研究方向：骨质疏松;筛查;成本效益分析 经验分享：大家好，我准备投一篇关于新的骨质疏松筛查工具的成本效益文章，因为一般这种文章文献数量很多所以我最后文献超了（要求45 我现在55）。请问各位这个如果投稿会被直接拒稿吗？还是可以在哪里说明一下？因为我看这个榨汁之前发表的一些成本效益分析文献数量也超过了45. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea56429884, createdName=ms6000000498436311, createdTime=Fri Jan 07 18:03:06 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181768, encodeId=1eac1181e6898, content=偏重的研究方向：骨质疏松 经验分享：20211227投的稿，30号状态更新editor assigned，至今状态不变，大家有经验吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37a06428636, createdName=ms8000001947639273, createdTime=Fri Jan 07 10:10:52 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095822, encodeId=f89c1095822bd, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566561, encodeId=506e56656109, content=20天审稿，给了3个月大修，一个月修回，一天接受，都没外送！神速！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27772543340, createdName=1252754dm51(暂无昵称), createdTime=Fri Feb 08 15:03:00 CST 2019, time=2019-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006118, encodeId=c5ab1006118e0, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：内固定物;有限元分析 经验分享：我8月2日投的，8月6日被拒绝！说他们编辑部讨论过我的文章，很遗憾不可以发表！没有任何修改意见……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d63b2925907, createdName=798200815, createdTime=Sun Aug 08 19:58:01 CST 2021, time=2021-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974458, encodeId=6d269e445829, content=偏重的研究方向：颌骨骨髓炎 经验分享：6.9投稿的，至今还在editor assigned，祈求好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/cx7lbf4aPYSqwzoXRP2UibyicD4eojmkpm4KjYpNROt1rmru0INbwt7bxcXh4v4fXLxCNvt08WZibBNkBWO7olZBQ/132, createdBy=6ad35224903, createdName=aqiongbb, createdTime=Thu Jun 17 19:53:30 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957199, encodeId=ea9995e19967, content=偏重的研究方向：生物力学;有限元分析 经验分享：我今天凌晨投稿的。不知道要等到什么时候了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d63b2925907, createdName=798200815, createdTime=Thu Apr 15 09:33:28 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553934, encodeId=9ddb553934b3, content=我是2月9投稿.目前还在审稿.焦急等待wxsession1f1cf044 2016-07-01 12:07:00 发表: 这个杂志我认为又快又好.我一个月接收, beContent=wxsession1f1cf044 2016-07-01 12:07:00 发表: 这个杂志我认为又快又好.我一个月接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/24/70bdcc438fd615b24ef997bb8d646928.jpg, createdBy=225f2012274, createdName=生如夏花之绚烂, createdTime=Tue Mar 20 00:00:00 CST 2018, time=2018-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548640, encodeId=2bcc548640b1, content=谢谢分享嚯嚯嚯 2017-08-11 16:57:00 发表: 好.值得一试, beContent=嚯嚯嚯 2017-08-11 16:57:00 发表: 好.值得一试, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/24/70bdcc438fd615b24ef997bb8d646928.jpg, createdBy=225f2012274, createdName=生如夏花之绚烂, createdTime=Fri Oct 27 00:00:00 CST 2017, time=2017-10-27, status=1, ipAttribution=)]

2019-02-08 1252754dm51(暂无昵称)

20天审稿，给了3个月大修，一个月修回，一天接受，都没外送！神速！

236 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1004453, encodeId=aa4d100445391, content=偏重的研究方向：骨质疏松 经验分享：请问initial submit 7.22，status date 7.27，还是显示editor assigned，预计还要多久会有结果 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9d325448092, createdName=ms1000000995331571, createdTime=Sun Aug 01 19:27:22 CST 2021, time=2021-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181918, encodeId=830b118191810, content=偏重的研究方向：骨质疏松;筛查;成本效益分析 经验分享：大家好，我准备投一篇关于新的骨质疏松筛查工具的成本效益文章，因为一般这种文章文献数量很多所以我最后文献超了（要求45 我现在55）。请问各位这个如果投稿会被直接拒稿吗？还是可以在哪里说明一下？因为我看这个榨汁之前发表的一些成本效益分析文献数量也超过了45. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea56429884, createdName=ms6000000498436311, createdTime=Fri Jan 07 18:03:06 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181768, encodeId=1eac1181e6898, content=偏重的研究方向：骨质疏松 经验分享：20211227投的稿，30号状态更新editor assigned，至今状态不变，大家有经验吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37a06428636, createdName=ms8000001947639273, createdTime=Fri Jan 07 10:10:52 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095822, encodeId=f89c1095822bd, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566561, encodeId=506e56656109, content=20天审稿，给了3个月大修，一个月修回，一天接受，都没外送！神速！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27772543340, createdName=1252754dm51(暂无昵称), createdTime=Fri Feb 08 15:03:00 CST 2019, time=2019-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006118, encodeId=c5ab1006118e0, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：内固定物;有限元分析 经验分享：我8月2日投的，8月6日被拒绝！说他们编辑部讨论过我的文章，很遗憾不可以发表！没有任何修改意见……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d63b2925907, createdName=798200815, createdTime=Sun Aug 08 19:58:01 CST 2021, time=2021-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974458, encodeId=6d269e445829, content=偏重的研究方向：颌骨骨髓炎 经验分享：6.9投稿的，至今还在editor assigned，祈求好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/cx7lbf4aPYSqwzoXRP2UibyicD4eojmkpm4KjYpNROt1rmru0INbwt7bxcXh4v4fXLxCNvt08WZibBNkBWO7olZBQ/132, createdBy=6ad35224903, createdName=aqiongbb, createdTime=Thu Jun 17 19:53:30 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957199, encodeId=ea9995e19967, content=偏重的研究方向：生物力学;有限元分析 经验分享：我今天凌晨投稿的。不知道要等到什么时候了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d63b2925907, createdName=798200815, createdTime=Thu Apr 15 09:33:28 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553934, encodeId=9ddb553934b3, content=我是2月9投稿.目前还在审稿.焦急等待wxsession1f1cf044 2016-07-01 12:07:00 发表: 这个杂志我认为又快又好.我一个月接收, beContent=wxsession1f1cf044 2016-07-01 12:07:00 发表: 这个杂志我认为又快又好.我一个月接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/24/70bdcc438fd615b24ef997bb8d646928.jpg, createdBy=225f2012274, createdName=生如夏花之绚烂, createdTime=Tue Mar 20 00:00:00 CST 2018, time=2018-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548640, encodeId=2bcc548640b1, content=谢谢分享嚯嚯嚯 2017-08-11 16:57:00 发表: 好.值得一试, beContent=嚯嚯嚯 2017-08-11 16:57:00 发表: 好.值得一试, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/24/70bdcc438fd615b24ef997bb8d646928.jpg, createdBy=225f2012274, createdName=生如夏花之绚烂, createdTime=Fri Oct 27 00:00:00 CST 2017, time=2017-10-27, status=1, ipAttribution=)]

2021-08-08 798200815

审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：内固定物;有限元分析
经验分享：我8月2日投的，8月6日被拒绝！说他们编辑部讨论过我的文章，很遗憾不可以发表！没有任何修改意见……

64 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1004453, encodeId=aa4d100445391, content=偏重的研究方向：骨质疏松 经验分享：请问initial submit 7.22，status date 7.27，还是显示editor assigned，预计还要多久会有结果 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9d325448092, createdName=ms1000000995331571, createdTime=Sun Aug 01 19:27:22 CST 2021, time=2021-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181918, encodeId=830b118191810, content=偏重的研究方向：骨质疏松;筛查;成本效益分析 经验分享：大家好，我准备投一篇关于新的骨质疏松筛查工具的成本效益文章，因为一般这种文章文献数量很多所以我最后文献超了（要求45 我现在55）。请问各位这个如果投稿会被直接拒稿吗？还是可以在哪里说明一下？因为我看这个榨汁之前发表的一些成本效益分析文献数量也超过了45. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea56429884, createdName=ms6000000498436311, createdTime=Fri Jan 07 18:03:06 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181768, encodeId=1eac1181e6898, content=偏重的研究方向：骨质疏松 经验分享：20211227投的稿，30号状态更新editor assigned，至今状态不变，大家有经验吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37a06428636, createdName=ms8000001947639273, createdTime=Fri Jan 07 10:10:52 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095822, encodeId=f89c1095822bd, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566561, encodeId=506e56656109, content=20天审稿，给了3个月大修，一个月修回，一天接受，都没外送！神速！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27772543340, createdName=1252754dm51(暂无昵称), createdTime=Fri Feb 08 15:03:00 CST 2019, time=2019-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006118, encodeId=c5ab1006118e0, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：内固定物;有限元分析 经验分享：我8月2日投的，8月6日被拒绝！说他们编辑部讨论过我的文章，很遗憾不可以发表！没有任何修改意见……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d63b2925907, createdName=798200815, createdTime=Sun Aug 08 19:58:01 CST 2021, time=2021-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974458, encodeId=6d269e445829, content=偏重的研究方向：颌骨骨髓炎 经验分享：6.9投稿的，至今还在editor assigned，祈求好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/cx7lbf4aPYSqwzoXRP2UibyicD4eojmkpm4KjYpNROt1rmru0INbwt7bxcXh4v4fXLxCNvt08WZibBNkBWO7olZBQ/132, createdBy=6ad35224903, createdName=aqiongbb, createdTime=Thu Jun 17 19:53:30 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957199, encodeId=ea9995e19967, content=偏重的研究方向：生物力学;有限元分析 经验分享：我今天凌晨投稿的。不知道要等到什么时候了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d63b2925907, createdName=798200815, createdTime=Thu Apr 15 09:33:28 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553934, encodeId=9ddb553934b3, content=我是2月9投稿.目前还在审稿.焦急等待wxsession1f1cf044 2016-07-01 12:07:00 发表: 这个杂志我认为又快又好.我一个月接收, beContent=wxsession1f1cf044 2016-07-01 12:07:00 发表: 这个杂志我认为又快又好.我一个月接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/24/70bdcc438fd615b24ef997bb8d646928.jpg, createdBy=225f2012274, createdName=生如夏花之绚烂, createdTime=Tue Mar 20 00:00:00 CST 2018, time=2018-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548640, encodeId=2bcc548640b1, content=谢谢分享嚯嚯嚯 2017-08-11 16:57:00 发表: 好.值得一试, beContent=嚯嚯嚯 2017-08-11 16:57:00 发表: 好.值得一试, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/24/70bdcc438fd615b24ef997bb8d646928.jpg, createdBy=225f2012274, createdName=生如夏花之绚烂, createdTime=Fri Oct 27 00:00:00 CST 2017, time=2017-10-27, status=1, ipAttribution=)]

2021-06-17 aqiongbb

偏重的研究方向：颌骨骨髓炎
经验分享：6.9投稿的，至今还在editor assigned，祈求好运。

62 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1004453, encodeId=aa4d100445391, content=偏重的研究方向：骨质疏松 经验分享：请问initial submit 7.22，status date 7.27，还是显示editor assigned，预计还要多久会有结果 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9d325448092, createdName=ms1000000995331571, createdTime=Sun Aug 01 19:27:22 CST 2021, time=2021-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181918, encodeId=830b118191810, content=偏重的研究方向：骨质疏松;筛查;成本效益分析 经验分享：大家好，我准备投一篇关于新的骨质疏松筛查工具的成本效益文章，因为一般这种文章文献数量很多所以我最后文献超了（要求45 我现在55）。请问各位这个如果投稿会被直接拒稿吗？还是可以在哪里说明一下？因为我看这个榨汁之前发表的一些成本效益分析文献数量也超过了45. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea56429884, createdName=ms6000000498436311, createdTime=Fri Jan 07 18:03:06 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181768, encodeId=1eac1181e6898, content=偏重的研究方向：骨质疏松 经验分享：20211227投的稿，30号状态更新editor assigned，至今状态不变，大家有经验吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37a06428636, createdName=ms8000001947639273, createdTime=Fri Jan 07 10:10:52 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095822, encodeId=f89c1095822bd, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566561, encodeId=506e56656109, content=20天审稿，给了3个月大修，一个月修回，一天接受，都没外送！神速！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27772543340, createdName=1252754dm51(暂无昵称), createdTime=Fri Feb 08 15:03:00 CST 2019, time=2019-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006118, encodeId=c5ab1006118e0, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：内固定物;有限元分析 经验分享：我8月2日投的，8月6日被拒绝！说他们编辑部讨论过我的文章，很遗憾不可以发表！没有任何修改意见……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d63b2925907, createdName=798200815, createdTime=Sun Aug 08 19:58:01 CST 2021, time=2021-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974458, encodeId=6d269e445829, content=偏重的研究方向：颌骨骨髓炎 经验分享：6.9投稿的，至今还在editor assigned，祈求好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/cx7lbf4aPYSqwzoXRP2UibyicD4eojmkpm4KjYpNROt1rmru0INbwt7bxcXh4v4fXLxCNvt08WZibBNkBWO7olZBQ/132, createdBy=6ad35224903, createdName=aqiongbb, createdTime=Thu Jun 17 19:53:30 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957199, encodeId=ea9995e19967, content=偏重的研究方向：生物力学;有限元分析 经验分享：我今天凌晨投稿的。不知道要等到什么时候了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d63b2925907, createdName=798200815, createdTime=Thu Apr 15 09:33:28 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553934, encodeId=9ddb553934b3, content=我是2月9投稿.目前还在审稿.焦急等待wxsession1f1cf044 2016-07-01 12:07:00 发表: 这个杂志我认为又快又好.我一个月接收, beContent=wxsession1f1cf044 2016-07-01 12:07:00 发表: 这个杂志我认为又快又好.我一个月接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/24/70bdcc438fd615b24ef997bb8d646928.jpg, createdBy=225f2012274, createdName=生如夏花之绚烂, createdTime=Tue Mar 20 00:00:00 CST 2018, time=2018-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548640, encodeId=2bcc548640b1, content=谢谢分享嚯嚯嚯 2017-08-11 16:57:00 发表: 好.值得一试, beContent=嚯嚯嚯 2017-08-11 16:57:00 发表: 好.值得一试, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/24/70bdcc438fd615b24ef997bb8d646928.jpg, createdBy=225f2012274, createdName=生如夏花之绚烂, createdTime=Fri Oct 27 00:00:00 CST 2017, time=2017-10-27, status=1, ipAttribution=)]

2021-04-15 798200815

偏重的研究方向：生物力学;有限元分析
经验分享：我今天凌晨投稿的。不知道要等到什么时候了。

59 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1004453, encodeId=aa4d100445391, content=偏重的研究方向：骨质疏松 经验分享：请问initial submit 7.22，status date 7.27，还是显示editor assigned，预计还要多久会有结果 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9d325448092, createdName=ms1000000995331571, createdTime=Sun Aug 01 19:27:22 CST 2021, time=2021-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181918, encodeId=830b118191810, content=偏重的研究方向：骨质疏松;筛查;成本效益分析 经验分享：大家好，我准备投一篇关于新的骨质疏松筛查工具的成本效益文章，因为一般这种文章文献数量很多所以我最后文献超了（要求45 我现在55）。请问各位这个如果投稿会被直接拒稿吗？还是可以在哪里说明一下？因为我看这个榨汁之前发表的一些成本效益分析文献数量也超过了45. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea56429884, createdName=ms6000000498436311, createdTime=Fri Jan 07 18:03:06 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181768, encodeId=1eac1181e6898, content=偏重的研究方向：骨质疏松 经验分享：20211227投的稿，30号状态更新editor assigned，至今状态不变，大家有经验吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37a06428636, createdName=ms8000001947639273, createdTime=Fri Jan 07 10:10:52 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095822, encodeId=f89c1095822bd, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566561, encodeId=506e56656109, content=20天审稿，给了3个月大修，一个月修回，一天接受，都没外送！神速！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27772543340, createdName=1252754dm51(暂无昵称), createdTime=Fri Feb 08 15:03:00 CST 2019, time=2019-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006118, encodeId=c5ab1006118e0, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：内固定物;有限元分析 经验分享：我8月2日投的，8月6日被拒绝！说他们编辑部讨论过我的文章，很遗憾不可以发表！没有任何修改意见……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d63b2925907, createdName=798200815, createdTime=Sun Aug 08 19:58:01 CST 2021, time=2021-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974458, encodeId=6d269e445829, content=偏重的研究方向：颌骨骨髓炎 经验分享：6.9投稿的，至今还在editor assigned，祈求好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/cx7lbf4aPYSqwzoXRP2UibyicD4eojmkpm4KjYpNROt1rmru0INbwt7bxcXh4v4fXLxCNvt08WZibBNkBWO7olZBQ/132, createdBy=6ad35224903, createdName=aqiongbb, createdTime=Thu Jun 17 19:53:30 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957199, encodeId=ea9995e19967, content=偏重的研究方向：生物力学;有限元分析 经验分享：我今天凌晨投稿的。不知道要等到什么时候了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d63b2925907, createdName=798200815, createdTime=Thu Apr 15 09:33:28 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553934, encodeId=9ddb553934b3, content=我是2月9投稿.目前还在审稿.焦急等待wxsession1f1cf044 2016-07-01 12:07:00 发表: 这个杂志我认为又快又好.我一个月接收, beContent=wxsession1f1cf044 2016-07-01 12:07:00 发表: 这个杂志我认为又快又好.我一个月接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/24/70bdcc438fd615b24ef997bb8d646928.jpg, createdBy=225f2012274, createdName=生如夏花之绚烂, createdTime=Tue Mar 20 00:00:00 CST 2018, time=2018-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548640, encodeId=2bcc548640b1, content=谢谢分享嚯嚯嚯 2017-08-11 16:57:00 发表: 好.值得一试, beContent=嚯嚯嚯 2017-08-11 16:57:00 发表: 好.值得一试, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/24/70bdcc438fd615b24ef997bb8d646928.jpg, createdBy=225f2012274, createdName=生如夏花之绚烂, createdTime=Fri Oct 27 00:00:00 CST 2017, time=2017-10-27, status=1, ipAttribution=)]

2018-03-20 生如夏花之绚烂

我是2月9投稿.目前还在审稿.焦急等待wxsession1f1cf044 2016-07-01 12:07:00 发表:
这个杂志我认为又快又好.我一个月接收

wxsession1f1cf044 2016-07-01 12:07:00 发表: 这个杂志我认为又快又好.我一个月接收

327 0

[GetPortalCommentsPageByObjectIdResponse(id=1004453, encodeId=aa4d100445391, content=偏重的研究方向：骨质疏松 经验分享：请问initial submit 7.22，status date 7.27，还是显示editor assigned，预计还要多久会有结果 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9d325448092, createdName=ms1000000995331571, createdTime=Sun Aug 01 19:27:22 CST 2021, time=2021-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181918, encodeId=830b118191810, content=偏重的研究方向：骨质疏松;筛查;成本效益分析 经验分享：大家好，我准备投一篇关于新的骨质疏松筛查工具的成本效益文章，因为一般这种文章文献数量很多所以我最后文献超了（要求45 我现在55）。请问各位这个如果投稿会被直接拒稿吗？还是可以在哪里说明一下？因为我看这个榨汁之前发表的一些成本效益分析文献数量也超过了45. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea56429884, createdName=ms6000000498436311, createdTime=Fri Jan 07 18:03:06 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181768, encodeId=1eac1181e6898, content=偏重的研究方向：骨质疏松 经验分享：20211227投的稿，30号状态更新editor assigned，至今状态不变，大家有经验吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37a06428636, createdName=ms8000001947639273, createdTime=Fri Jan 07 10:10:52 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095822, encodeId=f89c1095822bd, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566561, encodeId=506e56656109, content=20天审稿，给了3个月大修，一个月修回，一天接受，都没外送！神速！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27772543340, createdName=1252754dm51(暂无昵称), createdTime=Fri Feb 08 15:03:00 CST 2019, time=2019-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006118, encodeId=c5ab1006118e0, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：内固定物;有限元分析 经验分享：我8月2日投的，8月6日被拒绝！说他们编辑部讨论过我的文章，很遗憾不可以发表！没有任何修改意见……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d63b2925907, createdName=798200815, createdTime=Sun Aug 08 19:58:01 CST 2021, time=2021-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974458, encodeId=6d269e445829, content=偏重的研究方向：颌骨骨髓炎 经验分享：6.9投稿的，至今还在editor assigned，祈求好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/cx7lbf4aPYSqwzoXRP2UibyicD4eojmkpm4KjYpNROt1rmru0INbwt7bxcXh4v4fXLxCNvt08WZibBNkBWO7olZBQ/132, createdBy=6ad35224903, createdName=aqiongbb, createdTime=Thu Jun 17 19:53:30 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957199, encodeId=ea9995e19967, content=偏重的研究方向：生物力学;有限元分析 经验分享：我今天凌晨投稿的。不知道要等到什么时候了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d63b2925907, createdName=798200815, createdTime=Thu Apr 15 09:33:28 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553934, encodeId=9ddb553934b3, content=我是2月9投稿.目前还在审稿.焦急等待wxsession1f1cf044 2016-07-01 12:07:00 发表: 这个杂志我认为又快又好.我一个月接收, beContent=wxsession1f1cf044 2016-07-01 12:07:00 发表: 这个杂志我认为又快又好.我一个月接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/24/70bdcc438fd615b24ef997bb8d646928.jpg, createdBy=225f2012274, createdName=生如夏花之绚烂, createdTime=Tue Mar 20 00:00:00 CST 2018, time=2018-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548640, encodeId=2bcc548640b1, content=谢谢分享嚯嚯嚯 2017-08-11 16:57:00 发表: 好.值得一试, beContent=嚯嚯嚯 2017-08-11 16:57:00 发表: 好.值得一试, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/24/70bdcc438fd615b24ef997bb8d646928.jpg, createdBy=225f2012274, createdName=生如夏花之绚烂, createdTime=Fri Oct 27 00:00:00 CST 2017, time=2017-10-27, status=1, ipAttribution=)]

2017-10-27 生如夏花之绚烂

谢谢分享嚯嚯嚯 2017-08-11 16:57:00 发表:
好.值得一试

嚯嚯嚯 2017-08-11 16:57:00 发表: 好.值得一试

287 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务